New “Know Your CML” App just launched
"Know your CML" is a new mobile app developed by CML Advocates Network. It offers a range of features to assist patients and caregivers in understanding various aspects of living with CML and provides articles and news related to CML.
By inputting valuable data, patients will be able to follow their response to treatment, find patient organisations near them, provide information relating to the quality of life as well as the availability of treatments in their country as well as reporting side effects. They will also be able to better understand CML through quizzes and other resources to assist them on their journey.
We have prepared a Webinar that launched our breakthrough App, to share with the CML Community. Look at the video by clicking here:
SAVE THE DATE: CML Horizons 2022
Date: 28 - 30 October 2022 Location: Marrakesh, Morocco
Dear members & friends of CML Advocates Network,
It is our pleasure to announce the dates for CML Horizons 2022. October 28 - 30 are the dates you need to block on your calendar, and the venue will be in Marrakesh, Morocco. The 20th CML Horizons should be an exciting event as we recognise the challenges that have been faced over the past two years. By providing the most current information and resources, CML Advocates Network aims to meet the needs of members by providing them with the most up-to-date information and resources, so that the CML Community can continue to: share, grow, and learn.
CML Advocates Network co-founders receive the 2022 iCMLf Prize
During the month of March 2022, the International CML Foundation announced the iCMLf Prizes for 2022. These prestigious global awards are conferred on individuals who have played a major role in advancing the understanding and management of CML.
On this ocassion, Giora Sharf and Jan Geissler, chronic myeloid leukemia (CML) patient advocates and co-founders of the CML Advocates Network, have been awarded the 2022 iCMLf Prize for their achievements in the field of patient advocacy using the experience of their own diagnosis to help other patients across the world.
Apply for an EHA 2022 Fellowship until 17th April
The European Hematology Association (EHA) has already opened the Fellowship Application and Registration process by providing 100 Full registration fellowships for leaders of hematology patient organisations.
This year, EHA is organizing its first hybrid EHA22 Congress in Vienna, Austria, and again providing patient advocates the opportunity to attend the conference both in-person and virtually from June 9 to 17.
If you are a representative of a CML patient organisation interested in attending this Congress, you have the possibility to apply for an EHA Fellowship and attend the 27th EHA Congress HERE.
Calling CML patients living in Ukraine
CML Advocates Network stands in solidarity with the CML patients in Ukraine.

CML Advocates Network statement supporting fellow members and patients in Ukraine.
The CML Advocates Network is an active network specifically for leaders of Chronic Myeloid Leukemia (CML) patient groups, connecting 128 patient organisations in 93 countries on all continents. It was set-up and is run by CML patients
In the light of recent geopolitical events in Ukraine we fully support our members and patients and families living with CML.
Following the recent COVID-19 pandemic during which care for so many patients living with cancer has undeniably suffered it is unfortunate that the recent series of events has ocurred and will certainly prolong the effects on those living with cancer and with CML in Ukraine.
As a patient-led global organisation it has always been our belief that disease has no borders and we have always working together both within CML and with the wider patient community to advance the voice of those who have been touched by disease and their families in order to highlight its effect on society.
We stand by our fellow members and patients in Ukraine and with wider global community in asking for common sense and diplomacy to prevail so that normal people living their lives can continue as such and in particular those who find themselves living with cancer and in our case CML can access the care and treatment that they fundamentally need.
As CML Advocates Network we stand by our members and their families and the wider medical community affected during these times.